ORGANIC
LETTERS
2012
Vol. 14, No. 8
1970–1973
Dual Brønsted Acid/Nucleophilic Activation
of Carbonylimidazole Derivatives
Stephen T. Heller, Tingting Fu, and Richmond Sarpong*
Department of Chemistry, University of California, Berkeley, California 94720, United States
Received February 10, 2012
ABSTRACT
Carbonylimidazole derivatives have been found to be highly active acylation reagents for esterification and amidation in the presence of
pyridinium salts. These reactions are thought to involve both Brønsted acid and nucleophilic catalysis. This mode of activation has been applied
to the synthesis of difficult to access oxazolidinones, as well as esters and amides. Finally, the use of pyridinium salts has been shown to
accelerate the esterification of carboxylic acids with imidazole carbamates.
Carbonylimidazole derivatives constitute an important
and versatile class of acylation reagents, particularly in the
preparation of esters and amides.1 Recently we, as well as
Batey, haveexplored the chemistryof imidazolecarbamate
and carbamylimidazole derivatives as acylating reagents
that obviate the need to preform an acylimidazole.2 Like
their parent compound, 1,10-carbonylimidazole (CDI),
carbonylimidazole derivatives are attractive reagents be-
cause of their enhanced stability relative to acid halides.3
This property has led to their rapid adoption in industrial
chemistry for a variety of applications.4
However, because of their reduced reactivity relative to
carbonyl halides, carbonylimidazole derivatives are often
used in conjunction with an activating reagent. For in-
stance, Staabobservedthatmostalcoholsdo notreact with
acylimidazoles at room temperature but rapidly yield
esters in the presence of catalytic amounts of alkoxide.5
The carbonylimidazole group can also be activated by
engaging with electrophiles such as NBS6 or by alkylating
at the distal nitrogen of the imidazole nucleus.7 Alterna-
tively, displacement of the imidazole by coupling reagents
such as HOBt has been explored in the context of
amidation.8 Finally, we and others have investigated acti-
vation of these species through nitrogen protonation.9
However, the weak basicity of most carbonylimidazoles
makes Brønsted acid activation challenging. Keeping each
of the aforementioned activation strategies and their at-
tendant limitations in mind, we sought to develop alter-
native methods for the activation of carbonylimidazole
derivatives that would be mild, selective, and general.
As an entry into new activation paradigms, we chose to
study the synthesis of sterically encumbered oxazolidi-
nones that are inaccessible through simple treatment of
(1) (a) Staab, K. M.; Bauer, H.; Schneider, K. M. Azolides in Organic
Synthesis and Biochemistry; Wiley-VCH: Weinheim, 1998. (b) Armstrong,
A. In Encyclopedia of Reagents for Organic Synthesis; Paquette, L. A., Ed.;
John Wiley & Sons: Chichester, UK, 1995; Vol. 2, p 1006.
(2) (a) For synthesis of esters from imidazole carbamates, see: Heller,
S. T.; Sarpong, R. Org. Lett. 2010, 12, 4572. (b) For the synthesis of
amides from carbamylimidazoles, see: Grzyb, J. A.; Shen, M.; Yoshina-
Ishii, C.; Chi, W.; Brown, R. S.; Batey, R. A. Tetrahedron 2005, 61,
7153and references therein.
(5) Staab, H. A.; Mannschreck, A. Chem. Ber 1962, 95, 1284.
(6) Katsuki, T. Bull. Chem. Soc. Jpn. 1976, 49, 2019.
(7) (a) Esters from 1-acyl-3-alkylimidazolium salts: Kamijo, T.;
Harada, H.; Iizuka, K. Chem. Pharm. Bull. 1984, 32, 5044. (b) Ureas and
carbamates from carbamylimidazolium salts: Grzyb, J. A.; Batey, R. A.
Tetrahedron Lett. 2008, 52, 5279. (c) Carbamates from imidazolium
carboxylates: Ballatore, C.; Aspland, S. E.; Castillo, R.; Desharnais, J.;
Eustaquio, T.; Sun, C.; Castellino, A. J.; Smith, A. B. Bioorg. Med. Chem.
Lett. 2005, 15, 2477. (d) CDI can be activated using MeOTf: Saha, A. K.;
Rapoport, H.; Schultz, P. J. Am. Chem. Soc. 1989, 111, 4856.
(8) Dunn, P. J.; Hughes, M. L.; Searle, P. M.; Wood, A. S. Org.
Process Res. Dev. 2003, 7, 244.
(9) (a) See ref 2a. (b) Heller, S. T.; Sarpong, R. Tetrahedron 2011, 67,
8851. (c) Oakenfull, D. G.; Salvesen, K.; Jencks, W. P. J. Am. Chem. Soc.
1971, 93, 188. (d) Wolfenden, R.; Jencks, W. P. J. Am. Chem. Soc. 1961,
83, 4390. (e) Woodman, E. K.; Chaffey, J. G. K.; Hopes, P. A.; Hose,
D. R. J.; Gilday, J. P. Org. Process Res. Dev. 2009, 13, 106.
ꢀ
(3) Larrivee-Aboussafy, C.; Jones, B. P.; Price, K. E.; Hardink,
M. A.; McLaughlin, R. W.; Lillie, B. M.; Hawkins, J. L.; Vaidyanathan,
R. Org. Lett. 2010, 12, 324.
(4) (a) Carey, J. S.; Laffan, D.; Thomson, C.; Williams, M. T. Org.
Biomol. Chem. 2004, 4, 2337. (b) Dunn, P. J.; Hoffmann, W.; Kang, Y.;
Mitchell, J. C.; Snowden, M. J. Org. Process Res. Dev. 2005, 9, 956.
(c) Dale, D. J.; Dunn, P. J.; Golighty, C.; Hughes, M. L.; Levett, P. C.;
Pearce, A. K.; Searle, P. M.; Ward, G.; Wood, A. S. Org. Process Res.
Dev. 2000, 4, 17.
r
10.1021/ol300339q
Published on Web 04/02/2012
2012 American Chemical Society